Compound 48/80 induces endothelium-dependent and histamine release-independent relaxation in rabbit aorta

Nitric Oxide - Biology and Chemistry

Volumn 18, Issue 2, 2008, Pages 87-92

  Viaro, Fernanda ^a   Celotto, Andréa Carla ^a   Capellini, Verena Kise ^a   Baldo, Caroline Floreoto ^a   Rodrigues, Alfredo José ^a   Vicente, Walter V A ^a   Evora, Paulo Roberto B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Compound 48 80; Endothelium; Nitric oxide; Rabbit aorta; Vasorelaxation

Indexed keywords

4 METHOXY N METHYLPHENETHYLAMINE; CALCIUM; CALCIUM CHELATING AGENT; CARBON DIOXIDE; COMPOUND 48-80; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FORMALDEHYDE; GUANYLATE CYCLASE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; NITRIC OXIDE; OXYGEN; PHENYLEPHRINE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; AORTA; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM; ENZYME ACTIVATION; HISTAMINE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASODILATATION;

ANIMALS; AORTA; CIMETIDINE; ENDOTHELIUM, VASCULAR; ESTRENES; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; MALE; MUSCLE RELAXATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; P-METHOXY-N-METHYLPHENETHYLAMINE; PYRILAMINE; PYRROLIDINONES; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 38749148769     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2007.11.004     Document Type: Article

References (28)

1. Ryan M.J., and Brody M.J. Neurogenic and vascular stores of histamine in the dog. J. Pharmacol. Exp. Ther. 181 (1972) 83-91
2. Owen D.A. Histamine receptors in the cardiovascular. Gen. Pharmacol. 8 (1977) 141-156
3. Paton W.D. Compound 48/80: a potent histamine liberator. Br. J. Pharmacol. Chemother. 6 (1951) 499-508
4. Irman-Florjanc T., and Erjavec F. Compound 48/80 and substance P induced release of histamine and serotonin from rat peritoneal mast cells. Agents Actions 13 (1983) 138-141
5. Mousli M., Bronner C., Bockaert J., Rouot B., and Landry Y. Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol. Lett. 25 (1990) 355-357
6. Mousli M., Bronner C., Landry Y., Bockaert J., and Rouot B. Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett. 259 (1990) 260-262
7. Ko S.M., Kim M.K., and Kim J.C. The role of nitric oxide in experimental allergic conjunctivitis. Cornea 19 (2000) 84-91
8. Bronner C., Wiggins C., Monte D., Marki F., Capron A., Landry Y., and Franson R.C. Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet. Biochim. Biophys. Acta 920 (1987) 301-305
9. Gietzen K. Comparison of the calmodulin antagonists compound 48/80 and calmidazolium. Biochem. J. 216 (1983) 611-616
10. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
11. Gudermann T., Schoneberg T., and Schultz G. Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu. Rev. Neurosci. 20 (1997) 399-427
12. Rang H.P., Dale M.M., Ritter J.M., and Moore P.K. Farmacologia (2004), Elsevier, Rio de Janeiro
13. Casteels R., and Suzuki H. The effect of histamine on the smooth muscle cells of the ear artery of the rabbit. Pflugers Arch. 387 (1980) 17-25
14. Tenner Jr. T.E. Comparison of H2 receptor agonists in rabbit atria and aorta. Pharmacology 22 (1981) 227-234
15. Hill S.J. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42 (1990) 45-83
16. Tomita U., Inanobe A., Kobayashi I., Takahashi K., Ui M., and Katada T. Direct interactions of mastoparan and compound 48/80 with GTP-binding proteins. J. Biochem. (Tokyo) 109 (1991) 184-189
17. Tanaka T., Kohno T., Kinoshita S., Mukai H., Itoh H., Ohya M., Miyazawa T., Higashijima T., and Wakamatsu K. Alpha helix content of G protein alpha subunit is decreased upon activation by receptor mimetics. J. Biol. Chem. 273 (1998) 3247-3252
18. Takei M., Ueno M., and Endo K. Role of intracellular Ca2+ on histamine release from rat peritoneal mast cells. J. Pharm. Sci. 81 (1992) 518-520
19. McClain D.E., Donlon M.A., Hill T.A., and Catravas G.N. Early kinetics of Ca2+ fluxes and histamine release in rat mast cells stimulated with compound 48/80. Agents Actions 15 (1984) 279-284
20. Fulton D., Gratton J.P., and Sessa W.C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. J. Pharmacol. Exp. Ther. 299 (2001) 818-824
21. Fleming I., and Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) R1-R12
22. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605
23. Fleming I., Fisslthaler B., Dimmeler S., Kemp B.E., and Busse R. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ. Res. 88 (2001) E68-E75
24. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R., Reese C.B., and Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7 (1997) 261-269
25. Alessi D.R., Deak M., Casamayor A., Caudwell F.B., Morrice N., Norman D.G., Gaffney P., Reese C.B., MacDougall C.N., Harbison D., Ashworth A., and Bownes M. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7 (1997) 776-789
26. Byrne R.D., Rosivatz E., Parsons M., Larijani B., Parker P.J., Ng T., and Woscholski R. Differential activation of the PI 3-kinase effectors AKT/PKB and p70 S6 kinase by compound 48/80 is mediated by PKCalpha. Cell. Signal. 19 (2007) 321-329
27. Zhang X.P., and Hintze T.H. cAMP signal transduction induces eNOS activation by promoting PKB phosphorylation. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2376-H2384
28. Fleming I., and Busse R. Signal transduction of eNOS activation. Cardiovasc. Res. 43 (1999) 532-541